ResMed Inc (RMD)vsZEN Graphene Solutions Ltd (ZTEK)
RMD
ResMed Inc
$226.31
-0.82%
HEALTHCARE · Cap: $33.31B
ZTEK
ZEN Graphene Solutions Ltd
$0.57
-2.75%
HEALTHCARE · Cap: $63.02M
Smart Verdict
WallStSmart Research — data-driven comparison
ResMed Inc generates 572414% more annual revenue ($5.40B vs $942,880). RMD leads profitability with a 27.5% profit margin vs 0.0%. RMD earns a higher WallStSmart Score of 70/100 (B).
RMD
Strong Buy70
out of 100
Grade: B
ZTEK
Avoid23
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+14.4%
Fair Value
$303.30
Current Price
$226.31
$76.99 discount
Intrinsic value data unavailable for ZTEK.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 35.2%
Safe zone — low bankruptcy risk
Every $100 of equity generates 26 in profit
Keeps 28 of every $100 in revenue as profit
Revenue surging 73.1% year-over-year
Conservative balance sheet, low leverage
Areas to Watch
No major concerns identified
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
ROE of -56.6% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : RMD
The strongest argument for RMD centers on Operating Margin, Altman Z-Score, Return on Equity. Profitability is solid with margins at 27.5% and operating margin at 35.2%. Revenue growth of 11.0% demonstrates continued momentum.
Bull Case : ZTEK
The strongest argument for ZTEK centers on Revenue Growth, Debt/Equity. Revenue growth of 73.1% demonstrates continued momentum.
Bear Case : RMD
No major red flags identified for RMD, but monitor valuation.
Bear Case : ZTEK
The primary concerns for ZTEK are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
RMD profiles as a mature stock while ZTEK is a hypergrowth play — different risk/reward profiles.
RMD carries more volatility with a beta of 0.89 — expect wider price swings.
ZTEK is growing revenue faster at 73.1% — sustainability is the question.
RMD generates stronger free cash flow (311M), providing more financial flexibility.
Bottom Line
RMD scores higher overall (70/100 vs 23/100), backed by strong 27.5% margins and 11.0% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
ResMed Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions.
Visit Website →ZEN Graphene Solutions Ltd
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
ZEN Graphene Solutions Ltd (ZTEK) is a pioneering company in the field of materials technology, dedicated to the development and commercialization of graphene-based solutions that enhance a wide array of industrial applications. With its innovative proprietary extraction techniques, ZTEK produces high-purity graphene from natural graphite, aiming to revolutionize sectors such as environmental remediation, energy storage, and advanced manufacturing. The company’s robust focus on sustainability and continuous investment in research and development underscores its commitment to leading the graphene technology market. As ZTEK navigates opportunities for growth and innovation, it stands well-positioned to drive long-term shareholder value and meet the rising global demand for high-performance materials.
Visit Website →Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?